Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The BioEscalator’s inaugural Pitch Battle contest was held digitally at the pizza social on Friday 17 April. Eleven pitches in total were delivered by innovative companies in Oxford's medical research district, covering the broad range of drug discovery, drug development and diagnostics work being undertaken at the BioEscalator.

Congratulations to MiroBio who won the overall best pitch prize with Juliane Schwaderer, Chris Lynch and Sara de Silva delivering a slick overview of their work on harnessing the immune system’s natural control mechanisms to combat auto-immune diseases.

Other prizes were awarded to Nucleome Therapeutics for best Covid-19 response, Ochre Bio’s Jack O’Meara for best speaker, BioArchitech for best video/graphics & best joke, Theolytics for most likely future unicorn, PepGen for best explanation of technology & Ervaxx for most mentions of the BioEscalator - well done to Andrew Fadden for cramming in as many as he did!

Four of these companies have now been put through to the Pitch Finale which will be held digitally on Friday 15 May in collaboration with BIO international and generously supported by Santander Universities UK. We’re looking forward to a great event.

Find out more about the BioEscalator

Similar stories

New computational technique reveals changes to lung function post COVID-19 infection

A new study led by Oxford researchers found that prior COVID-19 infection was associated with more uneven inflation of the lungs during normal breathing, smaller lung volumes, and greater respiratory dead space.

Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.

Celebrating Childhood Cancer Awareness Month

September was Childhood Cancer Awareness Month, and researchers in Department of Paediatrics took action to help raise awareness for this cause.

New study shows higher rate of fractures in people with intellectual disability

In the most comprehensive study of its kind, researchers at the University of Oxford and Oxford Health NHS Foundation Trust found a substantially higher rate of fractures in people with intellectual disability compared with people of the same age and gender without an intellectual disability.

New evidence for how our brains handle surprise

A new study from the Bruno Group is challenging our perceptions of how the different regions of the cerebral cortex function. A group of ‘quiet’ cells in the somatosensory cortex that rarely respond to touch have been found to react mainly to surprising circumstances. The results suggest their function is not necessarily driven by touch, but may indicate an important and previously unidentified role across all the major cortices.